TYRUKO conc perf 300 mg/15ml flac 15 ml
7680695030013
CH-69503
L04AG03
01.99.0.
Reimbursement limitations:
TYRUKO.01
Au moment de la pose de l'indication ou avant le traitement, le risque de LEMP …
1 / 3
google
Details
- Product number
- 6950301
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- natalizumabum 300 mg, natrii chloridum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 15 ml corresp. natrium 51.73 mg.
Articles (1)
Tyruko 300mg / 15ml
15ml
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
51.73 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1194.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2025
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69503
- Drug name
- Tyruko, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AG03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 05/11/2024
- Authorization expiration date
- 04/11/2029
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TYRUKO conc perf 300 mg/15ml flac 15 ml
- Description (DE)
- TYRUKO Inf Konz 300 mg/15ml Durchstf 15 ml
- Market launch
- 28/05/2025
- Narcotic (BTM)
- No